Cytidine-5'-Monophosphate
- Generic Name
- Cytidine-5'-Monophosphate
- Drug Type
- Small Molecule
- Chemical Formula
- C9H14N3O8P
- CAS Number
- 63-37-6
- Unique Ingredient Identifier
- F469818O25
- Background
A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase.
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
Phase 3
Active, not recruiting
- Conditions
- Advanced MalignanciesNSCLCOvarian CancerUrothelial CancerSolid Tumors
- Interventions
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 67
- Registration Number
- NCT05059522
- Locations
- 🇺🇸
Highlands Oncology Group, PA, Springdale, Arkansas, United States
🇷🇺Budgetary Healthcare Institution of Omsk Region "Clinical Oncology Dispensary", Omsk, Omskaya Oblast', Russian Federation
🇺🇸MSK Monmouth, Middletown, New Jersey, United States
TCM in the Treatment of Lung Adenocarcinoma
Not Applicable
- Conditions
- Lung Adenocarcinoma
- Interventions
- Drug: Jing-yan-kang Granule
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Henan University of Traditional Chinese Medicine
- Target Recruit Count
- 144
- Registration Number
- NCT04482829
CMP vs Fascia Iliaca Block
Not Applicable
- Conditions
- Hip ArthroplastyPain, Postoperative
- Interventions
- Drug: Fascia Illica
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Loyola University
- Target Recruit Count
- 40
- Registration Number
- NCT04426058
- Locations
- 🇺🇸
Loyola University Medical Center, Maywood, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath